Write in a clean editor, then format for Journal of Biopharmaceutical Statistics in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Journal of Biopharmaceutical Statistics is a peer-reviewed journal published by Taylor & Francis, covering Statistical Methods in Clinical Trials, Optimal Experimental Design Methods, Statistical Methods and Bayesian Inference.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Journal of Biopharmaceutical Statistics 12 (3): 45–58.
Formats any DOI in Journal of Biopharmaceutical Statistics style. No sign-up. |
| Publishes research in | Statistical Methods in Clinical Trials Optimal Experimental Design Methods Statistical Methods and Bayesian Inference Statistical Methods and Inference Health Systems, Economic Evaluations, Quality of Life |
| ISSN | 1054-3406 |
| Citation impact (2-yr) | 0.86 |
| h-index | 72 |
| i10-index | 855 |
| Total citations | 34,257 |
| Top institutions publishing here | United States Food and Drug Administration |
| Journal website | www.tandfonline.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Limits of agreement provide a straightforward and intuitive approach to agreement between different methods for measuring the same quantity. When pairs of observations using the two methods are independent, i.e., on different subjects, the calculations are very simple and straightforward. Some authors collect repeated data, either as repeated pairs of measurements on the same subject,…
Weighted gene coexpression network analysis (WGCNA) has been applied to many important studies since its introduction in 2005. WGCNA can be used as a data exploratory tool or as a gene screening method; WGCNA can also be used as a tool to generate testable hypothesis for validation in independent data sets. In this article, we…
Treatment effects are often evaluated by comparing change over time in outcome measures. However, valid analyses of longitudinal data can be problematic when subjects discontinue (dropout) prior to completing the study. This study assessed the merits of likelihood-based repeated measures analyses (MMRM) compared with fixed-effects analysis of variance where missing values were imputed using the…
Reliable and accurate measurements serve as the basis for evaluation in many scientific disciplines. Issues related to reliable and accurate measurement have evolved over many decades, dating back to the nineteenth century and the pioneering work of Galton (1886), Pearson (1896, 1899, 1901), and Fisher (1925). Requiring a new measurement to be identical to the…
A PhRMA Working Group on adaptive clinical trial designs has been formed to investigate and facilitate opportunities for wider acceptance and usage of adaptive designs and related methodologies. A White Paper summarizing the findings of the group is in preparation; this article is an Executive Summary for that full White Paper, and summarizes the findings…
